Awm Investment Company, Inc. Reata Pharmaceuticals Inc Transaction History

Awm Investment Company, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $2 Million - $2.86 Million	-20,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $3.74 Million - $6.53 Million	-40,000 Reduced 66.67%	20,000 $1.95 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $1.86 Million - $3.72 Million	-15,000 Reduced 20.0%	60,000 $8.66 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $243,800 - $382,200	5,000 Added 7.14%	75,000 $4.21 Million
Q2 2018 Aug 09, 2018	BUY	$19.94 - $40.96 $99,700 - $204,800	5,000 Added 7.69%	70,000 $2.45 Million
Q1 2018 May 10, 2018	BUY	$20.0 - $30.19 $341,420 - $515,373	17,071 Added 35.62%	65,000 $1.33 Million
Q4 2017 Feb 13, 2018	SELL	$22.39 - $33.27 $2.5 Million - $3.72 Million	-111,736 Reduced 69.98%	47,929 $1.36 Million
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $4.2 Million - $5.09 Million	159,665	159,665 $4.97 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.